These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 3123435
1. Monoclonal antibody highly sensitive for the detection of ras p21 in immunoblotting analysis. Kanai T, Hirohashi S, Noguchi M, Shimoyama Y, Shimosato Y, Noguchi S, Nishimura S, Abe O. Jpn J Cancer Res; 1987 Dec; 78(12):1314-8. PubMed ID: 3123435 [Abstract] [Full Text] [Related]
3. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans. Ward JM, Perantoni AO, Santos E. Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257 [Abstract] [Full Text] [Related]
4. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse. Pullano TG, Sinn E, Carney WP. Oncogene; 1989 Aug; 4(8):1003-8. PubMed ID: 2474786 [Abstract] [Full Text] [Related]
5. Preparation, characterization and properties of monoclonal antibodies against intact H-ras p21 proteins. Sorrentino V, Nebreda AR, Alonso T, Santos E. Oncogene; 1989 Feb; 4(2):215-22. PubMed ID: 2467247 [Abstract] [Full Text] [Related]
6. Detection of Ki-ras proto-oncogene protein by a specific monoclonal antibody. Palejawala S, Goldsmith LT. Biotechniques; 1991 Nov; 11(5):606-8. PubMed ID: 1804249 [Abstract] [Full Text] [Related]
7. [Immunoassays of cancer markers--production and analysis of monoclonal antibodies reactive with ras oncogene p21]. Yoshida K, Shiku H. Tanpakushitsu Kakusan Koso; 1987 Sep; (31 Suppl):74-9. PubMed ID: 3321179 [No Abstract] [Full Text] [Related]
8. [Oncogene products as tumor markers]. Shiku H. Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2212-7. PubMed ID: 3300559 [Abstract] [Full Text] [Related]
9. Detection of c-ras gene mutation and expression of p21 protein in dysplasias and carcinomas complicating ulcerative colitis. Tsuda T, Mochizuki M, Wakasa H. J Gastroenterol; 1995 Nov; 30 Suppl 8():30-2. PubMed ID: 8563883 [Abstract] [Full Text] [Related]
10. Expression of p21 ras oncoproteins in human cancers. Tanaka T, Slamon DJ, Battifora H, Cline MJ. Cancer Res; 1986 Mar; 46(3):1465-70. PubMed ID: 3510727 [Abstract] [Full Text] [Related]
11. Characterization of monoclonal antibodies specific to the activated ras p21 with aspartic acid at position 13. La Vecchio JA, Hamer PJ, Ng SC, Trimpe KL, Carney WP. Oncogene; 1990 Aug; 5(8):1173-8. PubMed ID: 2202949 [Abstract] [Full Text] [Related]
12. Expression of normal and mutant ras proteins in human acute leukemia. Shen WP, Aldrich TH, Venta-Perez G, Franza BR, Furth ME. Oncogene; 1987 May; 1(2):157-65. PubMed ID: 3325880 [Abstract] [Full Text] [Related]
13. Possible binding proteins of ras p21 in human erythrocyte membrane. Tanimoto T. Kobe J Med Sci; 1990 Aug; 36(3-4):71-86. PubMed ID: 2096262 [Abstract] [Full Text] [Related]
14. Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers. Yoshida K, Hamatani K, Koide H, Ikeda H, Nakamura N, Akiyama M, Tsuchiyama H, Nakayama E, Shiku H. Cancer Res; 1988 Oct 01; 48(19):5503-9. PubMed ID: 3046740 [Abstract] [Full Text] [Related]
15. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis. Schwartz B, Benharroch D, Prinsloo I, Cagnano E, Lamprecht SA. Anticancer Res; 1995 Oct 01; 15(1):211-8. PubMed ID: 7537485 [Abstract] [Full Text] [Related]
16. Similarity of expression of low molecular weight G proteins smg p21A and ras p21 in normal and malignant human tissues. Takayama K, Furukawa K, Abe K, Kawase Y, Mizoguchi A, Kikuchi A, Takai Y, Matsui Y, Teranishi Y, Nakayama E. Cancer Res; 1991 Apr 15; 51(8):2223-8. PubMed ID: 1901241 [Abstract] [Full Text] [Related]
17. Geranylgeranyl as well as farnesyl moiety is transferred to Ras p21 overproduced in adrenocortical cells transformed by c-Ha-rasEJ oncogene. Osman H, Mazet JL, Maume G, Maume BF. Biochem Biophys Res Commun; 1997 Feb 24; 231(3):789-92. PubMed ID: 9070894 [Abstract] [Full Text] [Related]
18. Analysis of ras gene expression in stomach cancer by anti-ras p21 monoclonal antibodies. Yoshida K, Hamatani K, Koide H, Abe Y, Ikeda H, Tsuchiyama H, Nakayama E, Shiku H. Cancer Detect Prev; 1988 Feb 24; 12(1-6):369-76. PubMed ID: 3052835 [Abstract] [Full Text] [Related]
19. Presence and possible role of c-ras and nuclear (c-fos and c-jun) proto-oncogene products in preimplantation embryonic development in mice. Ahmad K, Naz RK. Mol Reprod Dev; 1993 Nov 24; 36(3):297-306. PubMed ID: 8286110 [Abstract] [Full Text] [Related]
20. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas. Hand PH, Vilasi V, Thor A, Ohuchi N, Schlom J. J Natl Cancer Inst; 1987 Jul 24; 79(1):59-65. PubMed ID: 3298786 [Abstract] [Full Text] [Related] Page: [Next] [New Search]